Sarepta Therapeutics (NASDAQ:SRPT): Q1 Non-GAAP EPS of -$1.04 misses by $1.75; GAAP EPS of -$0.23 misses by $0.67.
Revenue of $100.4M (+15.4% Y/Y) misses by $17.78M.
https://seekingalpha.com/news/3570415-sarepta-therapeutics-eps-misses-1_75-misses-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.